ORGANIZATION

• FY2026 Reform Tilted toward Price Cuts despite Spillover Scrap: FPMAJ Chair
  January 6, 2026

• Pfizer Japan President Igarashi Takes Helm as PhRMA Japan Chair
  January 6, 2026

• Industry Leaders Call for Proper Rewards for Innovation in New Year Messages
  January 5, 2026

• Generic Use Rate Rises Further to 89.5% in July-September: JGA
  January 5, 2026

• Trade Groups Hail Spillover Abolition, but Urge Further Overhauls
  December 26, 2025

• EFPIA Japan, Patient Groups Call for Stronger Health Literacy, PPI
  December 22, 2025

• JPMA Exec Renews Call for Simpler Drug Pricing System
  December 19, 2025

• JGA to Create “Stable Supply Network” Membership to Expand Ramp-Up Scheme
  December 18, 2025

• Pharma Groups Reiterate “No” to Broader CEA Use, Huge-Seller and Spillover Rules: Joint Statement
  December 17, 2025

• Japan Medical Societies Recommend RSV Vaccination for Older Adults
  December 15, 2025

• Labor Union Group Submits Request, Urges Drug Pricing Overhaul amid Inflation
  December 3, 2025

• Wholesalers Urge Caution on Debating 2% Buffer without Bigger Reform Picture
  November 28, 2025

• Labor Federation Files Request for 5% Drug Price Hike with Health Minister
  November 28, 2025

• Japan PBSS Launches to Buttress Drug Discovery via Grassroots Networks
  November 26, 2025

• Labor Group Presses Lawmakers to Reflect Rising Costs in Drug Prices
  November 26, 2025

• Industry Groups Call for More Efficient Clinical Trials in Japan: Joint Statement
  November 21, 2025

• PhRMA Chief Warns Japan Is Losing Its Appeal, Urges End to On-Patent Price Cuts
  November 19, 2025

• Policy Veterans’ Group Calls for Value-Based Pricing for Regenerative Medicine
  November 14, 2025

• JPMA Exec Urges Immediate Action on Inflation Pressures as Budget Talks Loom
  November 14, 2025

• JPMA’s Yoshida Urges Pro-Innovation Rules to Boost Japan’s Appeal amid MFN Fears
  November 11, 2025

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »